
Gemcitabine
Form: Lyophilized powder for solution for injection/infusion
Strength: 200 mg, 1000 mg, 1500 mg
Reference Brands: Gemzar® (US & EU)
Category: Oncology Cancer Care
Gemcitabine is a widely used oncology chemotherapy drug available in both the US and EU pharmaceutical B2B markets. Offered in 200 mg, 1 g, and 1.5 g vials, Gemcitabine comes as a lyophilized powder for intravenous infusion. Trusted by hospitals and oncology centers, it is essential for treating cancers such as pancreatic, lung, bladder, and breast cancer. Approved by the FDA and EMA, Gemcitabine is available through certified pharmaceutical wholesalers and B2B distributors across Europe and the United States. Buyers seeking reliable Gemcitabine suppliers can access competitive pricing, consistent quality, and regulatory-compliant sourcing for hospital and clinical use.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View Details Get EnquiryDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View Details Get EnquirySunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View Details Get EnquiryIfosfamide
Strength: 1 g/vial,2 g/vial, 3 g/vial
Form: Injection
Reference Brands: Ifex® (US), Holoxan® (EU)
View Details Get Enquiry